Quince Therapeutics Inc
NASDAQ:QNCX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Quince Therapeutics Inc
NASDAQ:QNCX
|
US |
|
Bank of Georgia Group PLC
LSE:BGEO
|
UK |
Shareholder Yield
Current shareholder yield for
QNCX is
.
Peers Comparison
Shareholder Yield
Price Appreciation
QNCX Price
Quince Therapeutics Inc
| Average Annual Return | -10.65% |
| Standard Deviation of Annual Returns | 86.32% |
| Max Drawdown | -100% |
| Market Capitalization | 15.8m USD |
| Shares Outstanding | 16 300 000 |
| Percentage of Shares Shorted | 10.82% |
QNCX Return Decomposition
Main factors of price return
Stock Splits
QNCX's latest stock split occurred on Apr 13, 2026
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, QNCX traded at 0.1363 per share. Afterward, the share price was about 1.41.
The adjusted shares began trading on Apr 13, 2026. This was the only stock split in QNCX's history.